CLINICAL TRIALS 2.0 Trademark

Trademark Overview

On Thursday, June 12, 2008, a trademark application was filed for CLINICAL TRIALS 2.0 with the United States Patent and Trademark Office. The USPTO has given the CLINICAL TRIALS 2.0 trademark a serial number of 77497490. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 29, 2016. This trademark is owned by Healogica, Inc.. The CLINICAL TRIALS 2.0 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing an interactive website to facilitate the interaction of patients and medical researchers in the field of medical clinical trials
clinical trials 2.0

General Information

Serial Number77497490
Word MarkCLINICAL TRIALS 2.0
Filing DateThursday, June 12, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 29, 2016
Registration Number3645156
Registration DateTuesday, June 23, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"CLINICAL TRIALS"
Goods and Servicesproviding an interactive website to facilitate the interaction of patients and medical researchers in the field of medical clinical trials
Pseudo MarkCLINICAL TRIALS TWO POINT ZERO

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 29, 2016
Primary Code042
First Use Anywhere DateThursday, May 7, 2009
First Use In Commerce DateThursday, May 7, 2009

Trademark Owner History

Party NameHealogica, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10023
Party NameHealogica, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10023

Trademark Events

Event DateEvent Description
Friday, January 29, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, June 23, 2009REGISTERED-SUPPLEMENTAL REGISTER
Thursday, May 21, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 20, 2009APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, May 20, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, May 20, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 20, 2009EXAMINERS AMENDMENT E-MAILED
Wednesday, May 20, 2009EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 20, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, May 20, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 20, 2009EXAMINERS AMENDMENT E-MAILED
Wednesday, May 20, 2009EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 20, 2009USE AMENDMENT ACCEPTED
Monday, May 18, 2009DATA MODIFICATION COMPLETED
Thursday, May 14, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 14, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 12, 2009TEAS AMENDMENT OF USE RECEIVED
Tuesday, May 12, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 12, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 11, 2009ASSIGNED TO LIE
Monday, May 11, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 24, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 24, 2009NON-FINAL ACTION E-MAILED
Friday, April 24, 2009NON-FINAL ACTION WRITTEN
Wednesday, March 18, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 18, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 18, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 10, 2009AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, February 10, 2009USE AMENDMENT FILED
Monday, February 9, 2009TEAS AMENDMENT OF USE RECEIVED
Saturday, September 20, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 20, 2008NON-FINAL ACTION E-MAILED
Saturday, September 20, 2008NON-FINAL ACTION WRITTEN
Friday, September 19, 2008ASSIGNED TO EXAMINER
Monday, June 16, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

trials clinical medical researchers field patients interactive website facilitate interaction